ANESI LAB INSTITUTE, a cosmeceutical range based on biotechnological, botanical and vegetable ingredients, presents LUMINOSITY, its depigmentation line that combines powerful inhibitors of melanin with the latest generation of encapsulated alphananohydroxy acids, which prevent the irregular production of melanin, thus inhibiting the melanocytes, to produce bright and radiant skin.
Luminosity responds effectively and visibly to blemishes and a lack of brightness, as it is the first cosmetic treatment to approach hyperpigmentation in a complete way, both on the surface and deep down.
This revolution in the treatment of blemishes has been possible thanks to scientific studies carried out recently, which demonstrate the important role of fibroblasts in hyperpigmentation.
We now know that it is essential to treat both dermal and epidermal causes.
And this is precisely what LUMINOSITY offers its clients, exclusively for the first time ever.
Blemishes are produced by an increase in the production of melanin by melanocytes, a small percentage of cells at the base of the epidermis. When these melanocytes have been exposed to sunlight and excessive doses of free radicals, this causes an overproduction of irregularly shaped melanin.
To treat blemishes, LUMINOSITY provides a new and evolved response to current blemish treatments. It involves directing its action towards the origin of hyperpigmentation and not just “blurring” them superficially.
ANESI LAB INSTITUTE LUMINOSITY focuses on treating all types of pigmentation spots, whatever their cause, with visible and long-lasting results thanks to 2 fundamental actions:
Using the latest generation of biotechnological ingredients and nanoencapsulated active ingredients (able to penetrate more deeply) to treat existing blemishes, both superficially and deep down, thanks to its action in both the epidermis and the dermis.
Protecting the skin from the sun with high SPF levels that prevent the appearance of new blemishes and the recurrence of existing ones.